A comparative trial between the therapeutic efficacy of topical 2% sertaconazole cream and 1% terbinafine cream in the treatment of  tinea cruris/tinea corporis

Sumyuktha J.; Murali Narasimhan; Parveen Basher Ahamed

doi:10.18203/issn.2455-4529.IntJResDermatol20170082

Authors

Sumyuktha J. Department of Dermatology, SRM Medical College and Research Centre, Kattankulathur, Potheri – Kanchipuram, India
Murali Narasimhan Department of Dermatology, SRM Medical College and Research Centre, Kattankulathur, Potheri – Kanchipuram, India
Parveen Basher Ahamed Department of Dermatology, SRM Medical College and Research Centre, Kattankulathur, Potheri – Kanchipuram, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20170082

Keywords:

Sertaconazole, Terbinafine, Dermatophytosis

Abstract

Background: Skin infections caused by dermatophyte fungi account for 6% of dermatology consultations at our hospital and 3 to 4% worldwide. A variety of antifungal agents are available for topical use. Terbinafine 1% cream is considered the first line topical medication in the treatment of dermatophytosis. Sertaconazole 2% cream is a relatively new drug having antifungal as well as antiflammatory property. In this prospective study we sought to compare the safety and efficacy of topical 2% Sertaconazole and 1% Terbinafine creams in the treatment of localized tinea cruris and/or tinea corporis.

Methods: In this study, 80 patients were randomized into two groups of 40 each. Group A received 2% Sertaconazole cream while group B received Terbinafine 1% cream topical application twice daily for 4 weeks. Patients were followed up at the end of 2^nd and 4^th weeks for clinical, mycological (KOH mount and fungal culture) and complete cure (both clinical and mycological).

Results: The mean age of the patients studied was 27.97 years. Complete cure was achieved in 59.5% and 80% in group A and 71.4% and 90.9% in group B at the end of 2^nd and 4^th weeks respectively. Significant P values were observed if the results were compared within the group, between baseline and 2 weeks, baseline and 4^th week and also 2^nd and 4^th week. Clinically significant side effects were not observed in both the groups.

Conclusions: Although higher cure rates were observed in the Terbinafine treated group, the results were not statistically significant. It can be concluded from our study that Sertaconazole 2% cream is similar in efficacy to Terbinafine 1% cream in the treatment of localized tinea cruris and corporis.

Metrics

Metrics Loading ...

References

Mohanty JC, Mohanty SK, Sahoo RC, Sahoo AS, Prahraj CH. Incidence of Dermatophytosis in Orissa. Indian J Med Microbiol. 1998;16:78-80.

Singh S, Beena MP. Profile of Dermatophyte infections in Baroda. Indian J Dermatol Venereol Leprosy. 2003;69:281–3.

Sahoo AK, Mahajan R. Management of Tinea Corporis, Tinea Cruris and Tinea Pedis: A Comprehensive review. Indian Dermatol online J. 2016;7:77-86.

El – Gohary M, Van Zurren EJ, Fedorowickz Z, Burgess H, Doney L, Stuart B, et al. Topical antifungal treatments for tinea cruris and tinea corporis. Cochrane database system Rev. 2014;8:CD009992.

Shadomy S, Esoingel Ingroff A, Gebhart RJ: Invitro studies with SF 86-327, a new orally active allylamine derivative. Sabouraudia 1985;23:125-32.

Rhea MP, Theodore R. Topical antifungal agents. In: Wolverton SE. Comprehensive dermatologic drug therapy. 2nd edition. WB Saunders; 2001: 508-9.

Croxtall JD, Plosker GL. Sertaconazole: A review of its use in superficial mycoses in dermatology and gynaecology. Drugs. 2009;69:339-59.

Liebel F, Lyte P, Garay M, Babad J, Southall MD. Anti-inflammatory and anti-itch activity of Sertaconazole nitrate. Arch Dermatol Res. 2006;298:191-9.

Lakshmi V, Bengalorkar GM, Kumar S. Clinical efficacy of topical terbinafine versus luliconazole in the treatment of Tinea corporis / Tinea cruris patients. Br J Pharmacol. 2013;3(4);1001-14.

Budimulja U. Terbinafine 1% cream Vs Bifonazole 1% cream in the treatment of Tinea cruris. In J Dermatol. 1998;37:871-3.

Jerajani HR, Janaki C, Kumar S, Phiske M. Comparative assessment of the efficacy and safety of Sertaconazole 2% cream versus Terbinafine 1% versus Luliconazole 1% cream in patients with Dermatophytoses: A pilot study. Indian J Dermatol. 2013;58:34–8.

Rotta I, Ziegelmann PK, Otuki MF, Riveros BS, Bernardo NL, Correr CJ. Efficacy of topical antifungals in the treatment of Dermatophytosis. A mixed treatment comparison Meta-analysis involving 14 treatments. JAMA Dermatol. 2013;149:341-9.

Sumitha A, Geetha M, Shashikala GH, HS Somashekar, KS chandarn. Efficacy and safety of 1% terbinafine hydrochloride versus 2% Sertaconazole cream in the treatment of tinea corporis. Int J Basic Clin Pharmacol. 2015;4:474–8.

Chaudhary SV, Bisati S, Singh A, Koley S. Efficacy and safety of Terbinafine hydrochloride 1% cream Vs Sertaconazole nitrate 2 % Cruris: A comparative therapeutic trial. Indian J Dermatol. 2013;58:457- 60.

Tamilselvan A, Girisha G, Bhaskar V, Suthakaran R. Comparative evaluation of newer topical antifungal agents in the treatment of superficial fungal infections ( Tinea or Dermatophytic). Int Res J Pharm. 2013;4(6):224–8.